Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Net Sales
180.64
127.35
110.30
92.71
91.64
73.05
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
180.64
127.35
110.30
92.71
91.64
73.05
Raw Material Cost
96.91
69.44
59.11
53.21
53.09
41.33
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-2.02
-1.84
-0.35
-2.13
1.08
1.01
Employee Cost
25.78
15.76
14.59
11.43
9.90
10.07
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.01
-0.01
-0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
17.30
10.03
9.55
4.83
7.34
5.10
Total Expenditure (Excl Depreciation)
137.98
93.38
82.90
67.34
71.41
57.51
Operating Profit (PBDIT) excl Other Income
42.66
33.97
27.40
25.37
20.23
15.54
Other Income
2.12
1.13
2.41
2.85
1.29
0.77
Operating Profit (PBDIT)
44.78
35.10
29.81
28.22
21.52
16.31
Interest
5.45
4.34
5.51
3.79
2.22
2.05
Exceptional Items
0.00
-0.05
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
39.33
30.71
24.30
24.43
19.30
14.26
Depreciation
17.63
15.41
13.18
11.44
6.48
3.25
Profit Before Tax
21.69
15.29
11.10
12.98
12.82
11.01
Tax
2.23
3.55
2.56
4.15
6.59
2.06
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
19.46
11.74
8.55
8.83
6.23
8.95
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
19.46
11.74
8.55
8.83
6.23
8.95
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
19.46
11.74
8.55
8.83
6.23
8.95
Equity Capital
22.25
21.95
21.75
18.62
17.12
14.96
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
Diluted Earnings per share
4.59
2.08
0.98
2.16
0.07
1.2
Operating Profit Margin (Excl OI)
23.62%
26.67%
24.84%
27.36%
22.08%
21.27%
Gross Profit Margin
21.77%
24.11%
22.03%
26.35%
21.06%
19.52%
PAT Margin
10.77%
9.22%
7.75%
9.52%
6.8%
12.25%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Dec 2025 is 41.85% vs 15.46% in Dec 2024
Consolidate Net Profit
YoY Growth in nine months ended Dec 2025 is 65.76% vs 37.31% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Dec 2025 is 25.58% vs 23.98% in Dec 2024
Interest
YoY Growth in nine months ended Dec 2025 is 25.58% vs -21.23% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024
Compare Nine Monthly Results Of Sakar Healthcare With
Figures in Cr
Consolidate Nine Monthly Results
Change(INR)
Change(%)
Net Sales
180.64
510.19
-329.55
-64.59%
Other Operating Income
0.00
0.00
0.00
Total Operating income
180.64
510.19
-329.55
-64.59%
Raw Material Cost
96.91
271.70
-174.79
-64.33%
Purchase of Finished goods
0.00
6.03
-6.03
-100.00%
(Increase) / Decrease In Stocks
-2.02
-10.02
8.00
79.84%
Employee Cost
25.78
64.11
-38.33
-59.79%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.00
0.01
Selling and Distribution Expenses
0.00
94.51
-94.51
-100.00%
Other Expenses
17.30
0.00
17.30
Total Expenditure (Excl Depreciation)
137.98
426.33
-288.35
-67.64%
Operating Profit (PBDIT) excl Other Income
42.66
83.86
-41.20
-49.13%
Other Income
2.12
7.64
-5.52
-72.25%
Operating Profit (PBDIT)
44.78
91.50
-46.72
-51.06%
Interest
5.45
0.03
5.42
18,066.67%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
39.33
91.47
-52.14
-57.00%
Depreciation
17.63
18.91
-1.28
-6.77%
Profit Before Tax
21.69
72.56
-50.87
-70.11%
Tax
2.23
17.25
-15.02
-87.07%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
19.46
55.31
-35.85
-64.82%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
19.46
55.31
-35.85
-64.82%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
19.46
55.31
-35.85
-64.82%
Equity Capital
22.25
13.37
8.88
66.42%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Gross Profit Margin
21.77%
17.93%
0.00
3.84%
PAT Margin
10.77%
10.84%
0.00
-0.07%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 180.64 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 41.85% vs 15.46% in Dec 2024
Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 19.46 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 65.76% vs 37.31% in Dec 2024
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 42.66 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 25.58% vs 23.98% in Dec 2024
Nine Monthly - Interest
Interest 5.45 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 25.58% vs -21.23% in Dec 2024
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.62%
in Dec 2025Figures in %
YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024






